Literature DB >> 16053854

Specificity of meal pattern analysis as an animal model of determining temporomandibular joint inflammation/pain.

C A Kerins1, D S Carlson, R J Hinton, B Hutchins, D M Grogan, K Marr, P R Kramer, R D Spears, L L Bellinger.   

Abstract

Analyzing feeding behavior, and in particular meal duration, can be used as a biological marker for temporomandibular joint (TMJ) inflammation/pain. The present study determined the specificity of meal duration as a measure of TMJ inflammation/pain in a rodent model. The model was also used to test the efficacy of dexamethasone (DEX) as a treatment for TMJ inflammation/pain that was induced by TMJ injection of complete Freund's adjuvant (CFA). In the first study, anesthetized male Sprague-Dawley rats housed in computerized feeding modules received bilateral intra-articular knee injections of CFA or saline. The next day, CFA-injected rats had significant knee swelling and impaired mobility. Food intake in the CFA-injected group was reduced over the next two days and this was due to reduced meal number with no change in meal size. Notably, meal duration was normal in both the CFA and saline knee-injected groups. In the second study, male rats were assigned to one of four groups: Group 1, no CFA and no DEX treatment; Group 2, no CFA and treatment with DEX (0.4 mg/kg i.m. once daily); Group 3, bilateral TMJ CFA injection and no DEX treatment; and Group 4, bilateral TMJ CFA injection and treatment with DEX. CFA significantly increased TMJ swelling and stress-induced chromodacryorrhea in Group 3, but treatment with DEX attenuated these effects in Group 4. Compared to the controls, meal duration was significantly lengthened 24 and 48 h post-CFA injection in Group 3, whereas DEX treatment attenuated TMJ swelling, chromodacryorrhea and normalized meal duration. The data demonstrate that meal pattern analysis, and in particular meal duration, can be used as a non-invasive specific measure of TMJ inflammation/pain and can be used as a marker of DEX treatment efficacy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16053854     DOI: 10.1016/j.ijom.2004.08.010

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  20 in total

1.  Infusion of Gabrα6 siRNA into the trigeminal ganglia increased the myogenic orofacial nociceptive response of ovariectomized rats treated with 17β-estradiol.

Authors:  P R Kramer; L L Bellinger
Journal:  Neuroscience       Date:  2014-08-12       Impact factor: 3.590

2.  Meal duration as a measure of orofacial nociceptive responses in rodents.

Authors:  Phillip R Kramer; Larry L Bellinger
Journal:  J Vis Exp       Date:  2014-01-10       Impact factor: 1.355

3.  Capping a pulpotomy with calcium aluminosilicate cement: comparison to mineral trioxide aggregates.

Authors:  Phillip R Kramer; Karl F Woodmansey; Robert White; Carolyn M Primus; Lynne A Opperman
Journal:  J Endod       Date:  2014-04-08       Impact factor: 4.171

4.  Knockdown of Fcγ receptor III in an arthritic temporomandibular joint reduces the nociceptive response in rats.

Authors:  Phillip R Kramer; Jyoti Puri; Larry L Bellinger
Journal:  Arthritis Rheum       Date:  2010-10

5.  Use of the Operant Orofacial Pain Assessment Device (OPAD) to measure changes in nociceptive behavior.

Authors:  Ethan M Anderson; Richard Mills; Todd A Nolan; Alan C Jenkins; Golam Mustafa; Chris Lloyd; Robert M Caudle; John K Neubert
Journal:  J Vis Exp       Date:  2013-06-10       Impact factor: 1.355

6.  Modulation of temporomandibular joint nociception and inflammation in male rats after administering a physiological concentration of 17β-oestradiol.

Authors:  P R Kramer; L L Bellinger
Journal:  Eur J Pain       Date:  2012-06-19       Impact factor: 3.931

7.  Measuring persistent temporomandibular joint nociception in rats and two mice strains.

Authors:  Phillip R Kramer; Carolyn A Kerins; Emet Schneiderman; Larry L Bellinger
Journal:  Physiol Behav       Date:  2010-02-10

8.  The effects of cycling levels of 17beta-estradiol and progesterone on the magnitude of temporomandibular joint-induced nociception.

Authors:  P R Kramer; L L Bellinger
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

9.  The dolognawmeter: a novel instrument and assay to quantify nociception in rodent models of orofacial pain.

Authors:  John C Dolan; David K Lam; Stacy H Achdjian; Brian L Schmidt
Journal:  J Neurosci Methods       Date:  2010-01-21       Impact factor: 2.390

Review 10.  Emerging intra-articular drug delivery systems for the temporomandibular joint.

Authors:  Paschalia M Mountziaris; Phillip R Kramer; Antonios G Mikos
Journal:  Methods       Date:  2008-10-01       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.